President and CEO

Senior Vice President, Global Head of Supply Chain

Halozyme Announces Global Collaboration and License Agreement with Takeda to Develop and Commercialize Vedolizumab with ENHANZE®

Halozyme announces global collaboration, license agreement with Takeda

Lilly returns to Nimbus with $1.3B deal to create new oral obesity drug

Top China Pharma and Biotech Stocks to Watch, According to Bernstein

0.7777777910232544

Learning & Development Lead, Polycythemia Vera (PV), US Oncology

Takeda is a patient-focused company transforming patient care through the development of novel specialty pharmaceuticals. The Learning & Development Lead will lead initiatives to enhance field capabilities and design strategic training programs for the Oncology pipeline, focusing on disease state education and sales effectiveness.

0.6666666865348816

Learning & Development Lead, Patient Value and Access

Takeda is transforming patient care through the development of novel specialty pharmaceuticals and best in class patient support programs. The Learning & Development Lead will contribute to enhancing the capabilities of PVA field roles and develop training programs that align with organizational goals and future business needs.

Learning & Development Lead, Patient Value and Access, US Oncology

Learning And Development Lead, Polycythemia Vera (pv), Us Oncology

Learning And Development Lead, Polycythemia Vera (pv), Us Oncology in united states (1000+)

Learning & Development Lead, Polycythemia Vera (PV), US Oncology

Learning & Development Lead, Patient Value and Access, US Oncology